Brainsway (BRSYF) Common Equity (2018 - 2026)
Brainsway's (BRSYF) quarterly Common Equity came in at $440000.0 in Q2 2026, down 99.35% on a YoY basis from $68.1 million in Q2 2025, and little changed quarter-over-quarter from $439000.0 in Q1 2026.
Analysis
Brainsway (BRSYF) Common Equity (2018 - 2026) Analysis & Trends
Brainsway (BRSYF) has reported Common Equity for 9 consecutive years, with $440000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity fell 99.35% year-over-year to $440000.0; the trailing twelve-month figure through Jun 2026 stood at $440000.0 (down 99.35% YoY), and the FY2025 full-year result was $430000.0, down 99.31% from the prior year.
- Common Equity held at $440000.0 in Q2 2026 per BRSYF's latest filing, from $439000.0 in the prior quarter.
- Across five years, Common Equity topped out at $68.1 million in Q2 2025 and bottomed at $363000.0 in Q1 2022.
- Historically, Common Equity has averaged $14.7 million across 5 years, with a median of $416500.0 in 2025.
- The sharpest annual moves came in 2022 and 2024: Common Equity plunged 99.41% in 2022, then soared 11675.34% in 2024.
- Over 5 years, Common Equity stood at $45.4 million in 2022, then declined by 8.41% to $41.6 million in 2023, then jumped by 49.86% to $62.3 million in 2024, then sank by 99.31% to $430000.0 in 2025, then rose by 2.33% to $440000.0 in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $440000.0, $439000.0, and $430000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.94 Bn | 175.34 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Intuitive Surgical | 127.83 Bn | 122.62 Bn | 1.96 Bn | 18.30 Bn |
| 3 | Medtronic | 116.96 Bn | 108.14 Bn | 6.34 Bn | 50.85 Bn |
| 4 | Stryker | 104.44 Bn | 100.97 Bn | 4.50 Bn | 23.99 Bn |
| 5 | Boston Scientific | 63.87 Bn | 63.33 Bn | 3.85 Bn | 25.17 Bn |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.65 Bn | 1.35 Bn | 10.72 Bn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn | 21.60 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 2.62 Bn |
| 9 | Steris | 20.68 Bn | 20.20 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | 440,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 440,000.00 |
| Mar 31, 2026 | 439,000.00 |
| Dec 31, 2025 | 430,000.00 |
| Sep 30, 2025 | 418,000.00 |
| Jun 30, 2025 | 68.13 Mn |
| Mar 31, 2025 | 415,000.00 |
| Dec 31, 2024 | 62.31 Mn |
| Sep 30, 2024 | 367,000.00 |
| Jun 30, 2024 | 42.98 Mn |
| Mar 31, 2024 | 367,000.00 |
| Dec 31, 2023 | 41.58 Mn |
| Sep 30, 2023 | 365,000.00 |
| Jun 30, 2023 | 365,000.00 |
| Mar 31, 2023 | 364,000.00 |
| Dec 31, 2022 | 45.40 Mn |
| Sep 30, 2022 | 363,000.00 |
| Jun 30, 2022 | 363,000.00 |
| Mar 31, 2022 | 363,000.00 |
| Dec 31, 2021 | 57.33 Mn |
| Sep 30, 2021 | 58.26 Mn |